337 related articles for article (PubMed ID: 349096)
1. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
Washington JA II
J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies of cefamandole.
Bodey GP; Weaver S
Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
Fu KP; Neu HC
J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
[TBL] [Abstract][Full Text] [Related]
6. The in vitro spectrum of the cephalosporins.
Washington JA
Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
8. [Concept of class in relation to first-generation cephalosporins].
De Toffoli A; Fantin B; Vechiet D
Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
[TBL] [Abstract][Full Text] [Related]
9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
11. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
Finland M; Garner C; Wilcox C; Sabath LD
J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
Shah PM; Zwischenbrugger H; Stille W
MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
[TBL] [Abstract][Full Text] [Related]
18. [In vitro testing of newer cephalosporins (author's transl)].
Linzenmeier G; Rosenthal E
Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
[TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins.
Seneca H
Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701
[No Abstract] [Full Text] [Related]
20. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
